
Sign up to save your podcasts
Or


Discover how GLP-1 receptor agonists, a breakthrough in medical science, can help reduce alcohol consumption and improve quality of life. Join the 2nd Opinion podcast with Dr. Paul Kolodzik as he explains the science behind this "miracle drug" and shares insights on its potential to transform addiction treatment. Whether you're seeking new options or curious about cutting-edge health solutions, this episode offers valuable information for a wide audience interested in health, wellness, and innovative therapies. ( Ozempic is a trademark of Novo Nordisk. Dr. Paul Kolodzik has no association with Novo Nordisk )
By DR. Paul Kolodzik3.3
66 ratings
Discover how GLP-1 receptor agonists, a breakthrough in medical science, can help reduce alcohol consumption and improve quality of life. Join the 2nd Opinion podcast with Dr. Paul Kolodzik as he explains the science behind this "miracle drug" and shares insights on its potential to transform addiction treatment. Whether you're seeking new options or curious about cutting-edge health solutions, this episode offers valuable information for a wide audience interested in health, wellness, and innovative therapies. ( Ozempic is a trademark of Novo Nordisk. Dr. Paul Kolodzik has no association with Novo Nordisk )

1,362 Listeners

788 Listeners

3,499 Listeners

9,290 Listeners

638 Listeners

338 Listeners

149 Listeners

1,106 Listeners

616 Listeners

804 Listeners

49 Listeners

525 Listeners

219 Listeners

1,665 Listeners

9 Listeners